Effect of zinc supplementation on bone formation in hemodialysis patients with normal or low turnover bone

References

• Solomons NW. Update on zinc biology. Ann Nutr Metab. 2013;62(Supple 1):8–17
   PubMedGoogle Scholar
• Molokwu CO, Li YV. Zinc homeostasis and bone mineral density. Ohio Res Clin Rev. 2006;15:7–15
   Google Scholar
• Kawakubo A, Matsunaga T, Ishizaki H, Yamada S, Hayashi Y. Zinc as an essential trace element in the acceleration of matrix vesicles-mediated mineral deposition. Microsc Res Tech. 2011;74(12):1161–1165
   PubMedGoogle Scholar
• Seo HJ, Cho YE, Kim T, Shin HI, Kwun IS. Zinc may increase bone formation through stimulating cell proliferation, alkaline phosphatase activity and collagen synthesis in osteoblastic MC3T3-E1 cells. Nutr Res Pract. 2010;4(5):356–361
   PubMed Web of Science ®Google Scholar
• Alcantara EH, Lomeda RA, Feldmann J, Nixon GF, Beattie JH, Kwun IS. Zinc deprivation inhibits extracellular matrix calcification through decreased synthesis of matrix proteins in osteoblasts. Mol Nutr Food Res. 2011;55(10):1552–1560
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Uchiyama S. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Int J Mol Med. 2004;14(1):81–85
   PubMedGoogle Scholar
• Yamaguchi M, Igarashi A, Sakai M, Degawa H, Ozawa Y. Prolonged intake of dietary fermented isoflavone-rich soybean reinforced with zinc affects circulating bone biochemical markers in aged individuals. J Health Sci. 2005;51(2):191–196
   Google Scholar
• Peretz A, Papadopoulos T, Willems D, et al. Zinc supplementation increases bone alkaline phosphatase in healthy men. J Trace Elem Med Biol. 2001;15(2–3):175–178
   PubMedGoogle Scholar
• Park SH, Jia T, Qureshi AR, et al. Determinants and survival implications of low bone mineral density in end-stage renal disease patients. J Nephrol. 2013;26(3):485–494
   PubMedGoogle Scholar
• Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF. Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res. 2006;109(2):115–121
   PubMed Web of Science ®Google Scholar
• Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Vichinsky EP. Zinc supplementation improves bone density in patients with thalassemia: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2013;98(4):960–971
   PubMed Web of Science ®Google Scholar
• Hyun TH, Barrett-Connor E, Milne DB. Zinc intakes and plasma concentrations in men with osteoporosis: The Rancho Bernardo Study. Am J Clin Nutr. 2004;80(3):715–721
   PubMedGoogle Scholar
• Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4(5893):643–646
   PubMedGoogle Scholar
• Yamada S, Inaba M, Kurajoh M, et al. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: Independence from renal dysfunction. Clin Endocrinol. 2008;69(2):189–196
   PubMed Web of Science ®Google Scholar
• Dashti-Khavidaki S, Khalili H, Vahedi SM, Lessan-Pezeshki M. Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity. Saudi J Kidney Dis Transpl. 2010;21(4):641–645
   PubMedGoogle Scholar
• Cousins RJ. Gastrointestinal factors influencing zinc absorption and homeostasis. Int J Vitam Nutr Res. 2010;80(4–5):243–248
   PubMed Web of Science ®Google Scholar
• Ferreira A. Development of renal bone disease. Eur J Clin Invest. 2006;36(Suppl 2):2–12
   PubMedGoogle Scholar
• Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol. 1996;7(3):506–512
   PubMedGoogle Scholar
• Navarro-Alarcon M, Reyes-Pérez A, Lopez-Garcia H, Palomares-Bayo M, Olalla-Herrera M, Lopez-Martinez MC. Longitudinal study of serum zinc and copper levels in hemodialysis patients and their relation to biochemical markers. Biol Trace Elem Res. 2006;113(3):209–222
   PubMed Web of Science ®Google Scholar
• Shidara K, Inaba M, Okuno S, et al. Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int. 2008;82(4):278–287
   PubMedGoogle Scholar
• Hie M, Tsukamoto I. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. Eur J Pharmacol. 2011;668(1–2):140–146
   PubMedGoogle Scholar